Moreover, given the involvement of ACSL1 in favoring glycolysis [24], a potentially interesting treatment opportunity may arise from the combination of ACSL1 and glycolysis intermediates inhibition in colorectal cancer. This evidence concerns the gene ACSL1 and colorectal cancer.